4//SEC Filing
Marguglio David J. 4
Accession 0001593968-20-000523
CIK 0000887247other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:01 PM ET
Size
6.2 KB
Accession
0001593968-20-000523
Insider Transaction Report
Form 4
Marguglio David J.
Director
Transactions
- Sale
Common Stock
2020-02-24$0.60/sh−9,948$6,004→ 335,359 total
Holdings
- 5,884(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.615 to $0.608, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001461753
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:01 PM ET
- Size
- 6.2 KB